نتائج البحث

Novel Dolutegravir and Lenacapavir Resistance Patterns in Human Immunodeficiency Virus Type 2 Infection: A Case Report.

• Authors : Kampen, Jeroen J A van¹ (AUTHOR); Nood, Els van² (AUTHOR); Mahmud, Rizwan¹ (AUTHOR)

• Source: Open Forum Infectious Diseases. Jan2025, Vol. 12 Issue 1, p1-8. 8p.

تفاصيل العنوان

Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real World.

• Authors : Gea-Grela, Alejandro de¹ (AUTHOR); Micán, Rafael^1,2 (AUTHOR); Miguel, Rosa de^1,2 (AUTHOR)

• Source: Open Forum Infectious Diseases. Mar2025, Vol. 12 Issue 3, p1-5. 5p.

تفاصيل العنوان

Impact of Human Immunodeficiency Virus Drug Resistance Mutations Detected in Women Prior to Antiretroviral Therapy With Efavirenz + Tenofovir Disoproxil Fumarate + Lamivudine (or Emtricitabine).

• Authors : Boyce, Ceejay L^1,2 (AUTHOR); Sils, Tatiana² (AUTHOR); Milne, Ross S² (AUTHOR)

• Source: Open Forum Infectious Diseases. Jul2024, Vol. 11 Issue 7, p1-10. 10p.

تفاصيل العنوان

Chronic Nucleoside Reverse Transcriptase Inhibitors Disrupt Mitochondrial Homeostasis and Promote Premature Endothelial Senescence.

• Authors : Chen, Yi-Fan¹ (AUTHOR); Stampley, James E² (AUTHOR); Irving, Brian A^2,3 (AUTHOR)

Subjects: *NUCLEOSIDE reverse transcriptase inhibitors; *CARDIOVASCULAR diseases; *CARDIOVASCULAR development

• Source: Toxicological Sciences. Dec2019, Vol. 172 Issue 2, p445-456. 12p. 7 Graphs.

تفاصيل العنوان

Antiretroviral Therapy and Cardiovascular Risk in People With HIV in the United States—An Updated Analysis.

• Authors : Parra-Rodriguez, Luis¹ (AUTHOR) ; Sahrmann, John M¹ (AUTHOR); Butler, Anne M^1,2 (AUTHOR)

• Source: Open Forum Infectious Diseases. Sep2024, Vol. 11 Issue 9, p1-7. 7p.

تفاصيل العنوان

HIV Subtypes and Drug-resistance-associated Mutations in US Blood Donors, 2015–2020.

• Authors : Custer, Brian^1,2 (AUTHOR) ; Altan, Eda¹ (AUTHOR); Montalvo, Leilani¹ (AUTHOR)

• Source: Open Forum Infectious Diseases. Jul2024, Vol. 11 Issue 7, p1-8. 8p.

تفاصيل العنوان

Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed.

• Authors : Borghetti, Alberto¹ (AUTHOR) ; Ciccullo, Arturo² (AUTHOR); Lombardi, Francesca³ (AUTHOR)

• Source: Open Forum Infectious Diseases. May2024, Vol. 11 Issue 5, p1-6. 6p.

تفاصيل العنوان

Dolutegravir Resistance in African Programmatic Settings Among Patients With Failure of Dolutegravir-based ART.

• Authors : Murphy, Richard A^1,2 (AUTHOR) ; Bedesi, Pradeep H³ (AUTHOR); Perumal, Nirmala³ (AUTHOR)

• Source: Open Forum Infectious Diseases. Jul2024, Vol. 11 Issue 7, p1-4. 4p.

تفاصيل العنوان

Case Series of People With HIV on the Long-Acting Combination of Lenacapavir and Cabotegravir: Call for a Trial.

• Authors : Gandhi, Monica¹ (AUTHOR) ; Hill, Lucas² (AUTHOR); Grochowski, Janet¹ (AUTHOR)

• Source: Open Forum Infectious Diseases. Apr2024, Vol. 11 Issue 4, p1-6. 6p.

تفاصيل العنوان

Structural cumulative survival models for estimation of treatment effects accounting for treatment switching in randomized experiments.

• Authors : Ying, Andrew¹ (AUTHOR) ; Tchetgen, Eric J. Tchetgen¹ (AUTHOR)

Subjects: *TREATMENT effectiveness; *SURVIVAL analysis (Biometry); *NUCLEOSIDE reverse transcriptase inhibitors

• Source: Biometrics. Sep2023, Vol. 79 Issue 3, p1597-1609. 13p.

تفاصيل العنوان